Lipid mediator networks and leukocyte transmigration

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 73, Issue 3-4, 2005, Pages 197-202

  Louis, Nancy A ^a   Hamilton, Kathryn E ^a   Colgan, Sean P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID; CHEMOKINE; CYCLOOXYGENASE 2; CYTOKINE; LIPID; LIPOXIN; LIPOXYGENASE; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE;

CELL ADHESION; CELL INTERACTION; CELL MIGRATION; CELL POPULATION; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; FIBROBLAST; HUMAN; HYPOXIA; INFLAMMATION; LEUKOCYTE; MICROENVIRONMENT; NEUTROPHIL; PATHOPHYSIOLOGY; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; REVIEW; SMOOTH MUSCLE FIBER;

EID: 24344449159     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2005.05.006     Document Type: Article

References (75)

1. J.T. Dancey, K.A. Deubelbeiss, L.A. Harker, and C.A. Finch Neutrophil kinetics in man J. Clin. Invest. 58 1976 705 715
2. K. Ley Pathways and bottlenecks in the web of inflammatory adhesion molecules and chemoattractants Immunol. Res. 24 2001 87 95
3. Y. Shimizu, and D.M. Rose Ginsberg MH. Integrins in the immune system Adv. Immunol. 72 1999 325 380
4. R. Gonzalez-Amaro, and F. Sanchez-Madrid Cell adhesion molecules: selectins and integrins Crit. Rev. Immunol. 19 1999 389 429
5. K. Ley Integration of inflammatory signals by rolling neutrophils Immunol. Rev. 186 2002 8 18
6. E. Dejana, R. Spagnuolo, and G. Bazzoni Interendothelial junctions and their role in the control of angiogenesis, vascular permeability and leukocyte transmigration Thromb. Haemost. 86 2001 308 315
7. E. Dejana, M. Corada, and M.G. Lampugnani Endothelial cell-to-cell junctions FASEB J. 9 1995 910 918
8. R.E. Lewis, and H.J. Granger Diapedesis and the permeability of venous microvessels to protein macromolecules: the impact of leukotriene B4 (LTB4) Microsc. Res. 35 1988 27 47
9. B. Meyrick, L.H. Hoffman, and K.L. Brigham Chemotaxis of granulocytes across bovine pulmonary artery intimal explants without endothelial cell injury Tissue Cell 16 1984 1 16
10. J.O. Shaw, and P.M. Henson Pulmonary intravascular sequestration of activated neutrophils Am. J. Pathol. 108 1982 17 23
11. A. Huang, M. Furie, S. Nicholson, J. Fischbarg, L. Liebovitch, and S. Silverstein Effects of human neutrophil chemotaxis across human endothelial cell monolayers on the permeability of these monolayers to ions and macromolecules J. Cell. Physiol. 135 1988 355 366
12. K. Zen, and C.A. Parkos Leukocyte-epithelial interactions Curr. Opin. Cell. Biol. 15 2003 557 564
13. M.A. Arnaout, J. Pitt, H.J. Cohen, J. Melamed, F.S. Rosen, and H.R. Colten Defiency of a granulocyte-membrane glycoprotein (gp150) in a boy with recurrent bacterial infections N. Engl. J. Med. 306 1982 693 699
14. R.S. Blume, J.M. Bennett, and R.A. Yankee Defective granulocyte regulation in Chediak-Higashi syndrome N. Engl. J. Med. 279 1968 1009 1013
15. S.E. Salmon, M.J. Cline, J. Schultz, and R.I. Lehrer Myeloperoxidase deficiency. Immunologic study of a genetic leukocyte defect N. Engl. J. Med. 282 1970 250 253
16. T.A. Springer Adhesion receptors of the immune system Nature 346 1990 425 430
17. M. Van der Vieren, H. Le Trong, C.L. Wood, P.F. Moore, T. St John, D.E. Staunton, and W.M. Gallatin A novel leukointegrin, alpha d beta 2, binds preferentially to ICAM-3 Immunity 3 1995 683 690
18. I.G. Cambell, P.S. Freemont, W. Foulkes, and J. Trowsdale An ovarian tumor marker with homology to vaccinia virus contains an IgV-like region and multiple transmembrane domains Cancer Res. 52 1992 5416 5420
19. D. Cooper, F.P. Lindberg, J.R. Gamble, E.J. Brown, and M.A. Vadas Transendothelial migration of neutrophils involves integrin-associated protein (CD47) Proc. Natl. Acad. Sci. (USA) 92 1995 3978 3982
20. C.A. Parkos, S.P. Colgan, A. Liang, A. Nusrat, A.E. Bacarra, D.K. Carnes, and J.L. Madara CD 47 mediates post-adhesive events required for neutrophil migration across polarized intestinal epithelia J. Cell Biol. 132 1996 437 450
21. Y. Liu, H.J. Buhring, K. Zen, S.L. Burst, F.J. Schnell, I.R. Williams, and C.A. Parkos Signal regulatory protein (SIRPalpha), a cellular ligand for CD47, regulates neutrophil transmigration J. Biol. Chem. 277 2002 10028 10036
22. D.W. Lawrence, W.J. Bruyninckx, N.A. Louis, D.M. Lublin, G.L. Stahl, C.A. Parkos, and S.P. Colgan Anti-adhesive role of apical decay-accelerating factor (DAF, CD55) in human neutrophil transmigration across mucosal epithelia J. Exp. Med. 198 2003 999 1010
23. N.A. Louis, K.E. Hamilton, T. Kong, and S.P. Colgan HIF-dependent induction of apical CD55 coordinates epithelial clearance of neutrophils Faseb J. 19 2005 950 959
24. A. Nicholson-Weller, and C.E. Wang Structure and function of decay accelerating factor CD55 J. Lab. Clin. Med. 123 1994 485 491
25. S.P. Colgan Lipid mediators in epithelial cell-cell interactions Cell Mol. Life Sci. 59 2002 754 760
26. B. McMahon, and C. Godson Lipoxins: endogenous regulators of inflammation Am. J. Physiol. Renal Physiol. 286 2004 F189 F201
27. C.N. Serhan, and E. Oliw Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways J. Clin. Invest. 107 2001 1481 1489
28. S.P. Colgan, C.N. Serhan, C.A. Parkos, C. Delp-Archer, and J.L. Madara Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers J. Clin. Invest. 92 1993 75 82
29. C.N. Serhan, J.F. Maddox, N.A. Petasis, H.R. Brady, S.P. Colgan, and J.L. Madara Design of lipoxin A4 stable analogs that block human neutrophil transmigration and adhesion Biochemistry (USA) 34 1995 14609 14615
30. S. Fiore, and C.N. Serhan Lipoxin A4 receptor activation is distinct from that of the formyl peptide receptor in myeloid cells: inhibition of CD11/18 expression by lipoxin A4-lipoxin A4 receptor interaction Biochemistry 34 1995 16678 16686
31. 4 analogs with increased biologic activity FASEB J. 12 1998 487 494
32. 4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction J. Exp. Med. 183 1996 137 146
33. J. Claria, M.H. Lee, and C.N. Serhan Aspirin-triggered lipoxins (15-epi-LX) are generated by the human lung adenocarcinoma cell line (A549)-neutrophil interactions and are potent inhibitors of cell proliferation Mol. Med. 2 1996 583 596
34. 4 P.Y.K. Wong C.N. Serhan Cell-Cell Interactions in the Release of Inflammatory Mediators 1991 Plenum Press New York 185 192
35. S.E. Dahlen, L. Franzen, J. Raud, C.N. Serhan, P. Westlund, E. Wikstrom, T. Bjorck, H. Matsuda, S.E. Webber, and C.A. Veale Actions of lipoxin A4 and related compounds in smooth muscle preparations and on the microcirculation in vivo Adv. Exp. Med. Biol. 229 1988 107 130
36. 4 stable analogues J. Clin. Invest. 101 1998 819 826
37. B.D. Levy, C.B. Clish, B. Schmidt, K. Gronert, and C.N. Serhan Lipid mediator class switching during acute inflammation: signals in resolution Nat. Immunol. 2 2001 612 619
38. U.N. Das, E.J. Ramos, and M.M. Meguid Metabolic alterations during inflammation and its modulation by central actions of omega-3 fatty acids Curr. Opin. Clin. Nutr. Metab. Care 6 2003 413 419
39. A.P. Simopoulos Omega-3 fatty acids in inflammation and autoimmune diseases J. Am. Coll. Nutr. 21 2002 495 505
40. P.C. Calder Fatty acids and gene expression related to inflammation Nestle Nutr. Workshop Ser. Clin. Perform. Prog. 7 2002 19 36 Discussion 36-40
41. A. Belluzzi N-3 fatty acids for the treatment of inflammatory bowel diseases Proc. Nutr. Soc. 61 2002 391 395
42. A. Nakazawa, and T. Hibi Is fish oil (n-3 fatty acids) effective for the maintenance of remission in Crohn's disease? J. Gastroenterol. 35 2000 173 175
43. A. Belluzzi, C. Brignola, M. Campieri, A. Pera, S. Boschi, and M. Miglioli Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease N. Engl. J. Med. 334 1996 1557 1560
44. C.N. Serhan, S. Hong, K. Gronert, S.P. Colgan, P.R. Devchand, G. Mirick, and R.L. Moussignac Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals J. Exp. Med. 196 2002 1025 1037
45. V.L. Marcheselli, S. Hong, W.J. Lukiw, X. Hua Tian, K. Gronert, A. Musto, M. Hardy, J.M. Gimenez, N. Chiang, C.N. Serhan, and N.G. Bazan Novel docosanoids Inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression J. Biol. Chem. 278 2003 43807 43817
46. C.N. Serhan, C.B. Clish, J. Brannon, S.P. Colgan, N. Chiang, and K. Gronert Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing J. Exp. Med. 192 2000 1197 1204
47. C.N. Serhan Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution Prostaglandins Other Lipid Mediat. 68,69 2002 433 455
48. M. Arita, F. Bianchini, J. Aliberti, A. Sher, N. Chiang, S. Hong, R. Yang, N.A. Petasis, and C.N. Serhan Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1 J. Exp. Med. 201 2005 713 722
49. S.P. Colgan, G.T. Furuta, and C.T. Taylor Cytokines and epithelial function G. Hecht Microbial Pathogeneis and the Intestinal Epithelial Cell 2003 ASM Press Washington, DC 61 78
50. R.N. Dubois, S.B. Abramson, L. Crofford, R.A. Gupta, L.S. Simon, L.B. Van De Putte, and P.E. Lipsky Cyclooxygenase in biology and disease FASEB J. 12 1998 1063 1073
51. J.J. Haddad Science review: redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury: role for hypoxia-inducible factor-1 alpha Crit. Care 7 2003 47 54
52. S. Kokura, N. Yoshida, and T. Yoshikawa Anoxia/reoxygenation-induced leukocyte-endothelial cell interactions Free Rad. Biol. Med. 33 2002 427 432
53. S. Saadi, L.E. Wrenshall, and J.L. Platt Regional manifestations and control of the immune system FASEB J. 16 2003 849 856
54. J. Karhausen, V.H. Haase, and S.P. Colgan Inflammatory Hypoxia: Role of Hypoxia-Inducible Factor Cell Cycle 4 2005 256 258
55. J.S. Lewis, J.A. Lee, J.C. Underwood, A.L. Harris, and C.E. Lewis Macrophage responses to hypoxia: relevance to disease mechanisms J. Leukoc. Biol. 66 1999 889 900
56. T. Cramer, Y. Yamanishi, B.E. Clausen, I. Forster, R. Pawlinski, N. Mackman, V.H. Haase, R. Jaenisch, M. Corr, V. Nizet, G.S. Firestein, H.P. Gerber, N. Ferrara, and R.S. Johnson HIF-1 alpha is essential for myeloid cell-mediated inflammation Cell 112 2003 645 657
57. J.O. Karhausen, G.T. Furuta, J.E. Tomaszewski, R.S. Johnson, S.P. Colgan, and V.H. Haase Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis J. Clin. Invest. 114 2004 1098 1106
58. L.J. Marnett, S.W. Rowlinson, D.C. Goodwin, A.S. Kalgutkar, and C.A. Lanzo Arachidonic acid oxygenation by COX-1 and COX-2. Mechanisms of catalysis and inhibition J. Biol. Chem. 274 1999 22903 22906
59. S.T. Prigge, J.C. Boyington, M. Faig, K.S. Doctor, B.J. Gaffney, and L.M. Amzel Structure and mechanism of lipoxygenases Biochimie 79 1997 629 636
60. P.A. Mieyal, A. Bonazzi, H. Jiang, M.W. Dunn, and M.L. Schwartzman The effect of hypoxia on endogenous corneal epithelial eicosanoids Invest. Ophthalmol. Vis. Sci. 41 2000 2170 2176
61. S.P. Colgan, C.T. Taylor, S. Narravula, K. Synnestvedt, and E.D. Blume Endothelial COX-2 induction by hypoxia liberates 6-keto-PGF1 alpha, a potent epithelial secretagogue Adv. Exp. Med. Biol. 507 2002 107 112
62. J.L. Wilkinson-Berka Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide Curr. Pharm. Des. 10 2004 3331 3348
63. G.L. Semenza HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus Cell 107 2001 1 3
64. P.H. Maxwell, M.S. Wiesener, G.W. Chang, S.C. Clifford, E.C. Vaux, M.E. Cockman, C.C. Wykoff, C.W. Pugh, E.R. Maher, and P.J. Ratcliffe The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis Nature 399 1999 271 275
65. K. Tanimoto, Y. Makino, T. Pereira, and L. Poellinger Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein EMBO J. 19 2000 4298 4309
66. D. Lando, D.J. Peet, D.A. Whelan, J.J. Gorman, and L.W. Murray Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch Science 295 2002 858 861
67. X.H. Liu, A. Kirschenbaum, M. Lu, S. Yao, A. Dosoretz, J.F. Holland, and A.C. Levine Prostaglandin E2 induces hypoxia-inducible factor-1 alpha stabilization and nuclear localization in a human prostate cancer cell line J. Biol. Chem. 277 2002 50081 50086 Epub 2002 October 24
68. S.T. Palayoor, P.J. Tofilon, and C.N. Coleman Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1 alpha and HIF-2 alpha in prostate cancer cells Clin. Cancer Res. 9 2003 3150 3157
69. H. Zhong, M. Willard, and J. Simons NS398 reduces hypoxia-inducible factor (HIF)-1 alpha and HIF-1 activity: multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms Int. J. Cancer 112 2004 585 595
70. S. Fiorucci, J.L. Wallace, A. Mencarelli, E. Distrutti, G. Rizzo, S. Farneti, A. Morelli, J.L. Tseng, B. Suramanyam, W.J. Guilford, and J.F. Parkinson A {beta}-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction Proc. Natl. Acad. Sci. USA 101 2004 15736 15741 Epub 2004 October 25
71. A.T. Gewirtz, L.S. Collier-Hyams, A.N. Young, T. Kucharzik, W.J. Guilford, J.F. Parkinson, I.R. Williams, A.S. Neish, and J.L. Madara Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis J. Immunol. 168 2002 5260 5267
72. M. Kruschewski, T. Foitzik, A. Perez-Canto, A. Hubotter, and H.J. Buhr Changes of colonic mucosal microcirculation and histology in two colitis models: an experimental study using intravital microscopy and a new histological scoring system Dig. Dis. Sci. 46 2001 2336 2343
73. C.J. Hauser, R.R. Locke, H.W. Kao, J. Patterson, and R.D. Zipser Visceral surface oxygen tension in experimental colitis in the rabbit J. Lab. Clin. Med. 112 1988 68 71
74. O.A. Hatoum, D.G. Binion, M.F. Otterson, and D.D. Gutterman Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation Gastroenterology 125 2003 58 69
75. K. Yokoyama, H. Mitomi, K. Kobayashi, T. Katsumata, K. Saigenji, and I. Okayasu Obliterative arteritis with nitric oxide synthase and HLA-DR expression in Crohn's colitis Hepatogastroenterology 48 2001 401 407